Page 300 - Read Online
P. 300

laboratory tests about thyroid function, autoimmune   occlusive site and predilation was performed with
           antibodies, and vasculitis indicators were all normal.  a balloon  (2.5  mm  ×  15  mm) at 6 atm. Then, the
                                                              stent (4 mm × 40 mm Xpert Stent System) was deployed
           Digital subtraction angiography  (DSA) showed a    over the stenosis and postdilation was performed with a
           dissecting aneurysm of the C1 segment of right ICA   balloon at 6 atm. Angiography after stenting showed the
           and subtotal occlusion of the left ICA [Figure 1a and b].   revascularization of the subtotal stenosis and good flow
           Anterior communicating artery was open, and the left   across the stent with complete disappearance of this
           middle cerebral artery (MCA) territory got collateral   stenosis [Figure 1h]. After the procedure, antiplatelet
           blood flow from the right MCA [Figure 1c]. Severe   therapy (clopidogrel 75 mg and aspirin 100 mg daily)
           bilateral stenosis (> 70%) was also revealed on the V2   was sequentially administered for 3 months, and then
           segment of both vertebral arteries (VA) [Figure 1d‑f].   aspirin is taken prophylactically. During the follow‑up
           Then angioplasty and stenting was performed for this   period of 3 years, this patient was normal at 3 months
           young patient.                                     after discharged from our hospital, and no recurrent
                                                              stroke occurred.
           First,  the  vertebral  angioplasty  and  stenting  was
           performed and then the left ICA was stented because of   DISCUSSION
           the carotid sinus reaction. A dissecting stenosis on the
           initial segment of the left VA stenosis was found during   FMD is a noninflammatory, nonatherosclerotic vascular
           the angiography before stenting. Firstly, one expanding   disease that commonly involves the renal and internal
           stent was placed on the dissecting site, and then another   carotid arteries. The young patient has multiple
           two stents (4 mm × 60 mm and 4 mm × 40 mm) were    vascular stenoses, but no cerebrovascular risk factors;
           delivered and  deployed to  cover  the  long  stenotic   therefore, cFMD can be diagnosed. The prevalence of
           lesion. A final angiography demonstrated an excellent   symptomatic renal artery FMD is about 4 in 1000, and
           stent placement across the stenotic lesion of the left   the prevalence of cFMD is probably half that. [1‑4]  FMD
           VA and left vertebral angiogram revealed a good flow   usually affects the females from 15 to 50 years of age
           in vertebral and basilar arteries [Figure 1g].     and accounts for around 10% of cases of renal artery
                                                              stenosis. [1‑4]
           After advancing the 8F guiding catheter within
           the C1 segment of the left ICA, a microwire (0.014   Although the etiology of FMD is not well understood,
           inches) was delivered through the subtotal         several mechanisms have been proposed. For example,


















           a                        b                        c                        d

















           e                        f                        g                        h
           Figure 1: (a) The dissecting aneurysm on the C1 segment of right internal carotid artery; (b) “rat tail sign” of the left internal carotid artery before predilation; (c) the
           anterior communicating artery was open and the left middle cerebral artery territory got collateral blood flow from the right middle cerebral artery; (d‑f) severe bilateral
           stenosis on the V2 segment of both VAs; (g) left vertebral arteries after stenting; (h) left internal carotid artery after balloon predilation


            292                                           Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015  Neuroimmunol Neuroinflammation | Volume 2 | Issue 4 | October 15, 2015                           293
   295   296   297   298   299   300   301   302   303   304   305